Staphylococcus spp. were isolated from the ward environment and antibiotic susceptibility tests were performed. Twenty-nine strains out of 274 isolates were S. aureus, and 41
Introduction
Infection with Staphylococcus aureus is one of the most important nosocomial infections in the hospital, because a high frequency of methicillin resistance is found in S. aureus. Recently, genetic studies on the methicillin resistance have been encouraged1'2'3'4). The resistance is evoked by the penicillin-binding protein-2'(PBP-2') which is encoded in the chromosomal mecA gene. It was also reported that the mecA gene present in coagulase-negative staphylococci (CNS) is horizontally transferred to S. aureus5). In this experiment, we isolated Staphylococcus strains from the general ward of Tottori University Hospital and tested their drug susceptibility. Then, the mecA gene and femA strains of MRSA tested, but not in 5 strains of MSSA. Two strains of methicillin-resistant (MR) S. epidermidis and one of 2 MR-S. hominis strains contained the mecA gene. No mecA gene was detected in the methicillin-sensitive strains of S. epidermidis, S. hoininis or S. haemolyticus. Southern blot analysis using mecA and femA probes showed that femA and mecA genes were present in all the DNAs from the corresponding femA-or mecA-positive strains (Fig. 2) .
Discussion
We collected Stabhylococcus from the new ward environment of Tottori University Hospital over one year from 1991 to 1992, and tested their drug susceptibility"). The rates of isolation of S. aureus and of MRSA had gradually increased. The rates of isolation of S. aureus among Staphylococcus spp. and of MRSA among S. aureus strains in January 1992 were 22 and 43%, respectively. One year later, in this experiment, isolation rates for S. aureus and for MRSA among S. aureus were 10.6 and 41.4%, respectively ( Table 1) . As it was widely recognized in Japan that 50 to 60% of S. aureus strains isolated from inpatients was MRSA, it may have been reasonable to find that 40 to 45% of S. aureus strains in the environment were methicillin resistant.
A PCR-based test was developed for the detection of the mecA gene, which encodes methicillin resistance in S. aureus1'3). This technique was extensively used for the rapid identification of MRSA. However, it was found that the DNA from staphylococci other than S. aureus also encodes mecA. Other DNA regions of the mecA genes were also selected as a primer by some investigators'•s'1Q. Another gene, femA, has been characterized as essential for the expression of S. aureus1 Yokoyama13' used the DNA sequence encoding mecA and femA genes as a double primer. We had used a double primer encoding mecA and fen A genes for identifying MRSA by a single PCR test. Unexpectedly, the strain which was positive in the PCR test with the primer for the mecA gene or femA gene alone was negative in the PCR with the double primer. A strategy for selection of the double primer may be needed.
Throughout these experiments, some strains of methicillin-resistant Staphylococcus other than S. aureus (MR-CNS) were found not to contain mecA. This might be due to the diversity of DNA sequences of the gene which encodes the mecA product, or to an other celllular DNA which encodes methicillin resistance.
Alternatively, two regulatory mecA genes were found"); one is the mecI gene which suppresses the expression of the mecA gene, and the other is the mecRl gene which acts as an inducer of the mecA gene. Unusual expression of these regulatory genes for mecA might be responsible for methicillin resistance. Resolution of these discrepancies will require further studies.
At any rate, staphylococci isolated from a hospital ward were revealed to possess methicillin resistance at relatively high frequency, and a similar mecA gene was detected in S. aureus and also in CNS. If a compromised patient is contaminated with MR-staphylococci directly from the ward environment or from the medical staff, methicillin resistance is transferred to the patient's resident S. aureus, and an opportunistic and devilish infection might occur. Therefore, extreme care against MRSA and MR-CNS is necessary for clinical treatment of the compromised inpatients.
